Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Correlation of Gene Status and Clinical Outcomes in ESCC (ESCC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03831828
Recruitment Status : Unknown
Verified September 2018 by LiuJunFeng, Hebei Medical University Fourth Hospital.
Recruitment status was:  Recruiting
First Posted : February 6, 2019
Last Update Posted : February 8, 2019
Sponsor:
Collaborator:
OrigiMed
Information provided by (Responsible Party):
LiuJunFeng, Hebei Medical University Fourth Hospital

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The incidence of esophageal squamous cell carcinoma is highly regional and familial. The current treatment plan is based on the stage and location of the tumor.By studying the relationship between the status of different genes and prognosis, it can help doctors to develop precise and individualized treatment plans.

Condition or disease
Prognosis of Patients With ESCC

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Estimated Enrollment : 46 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Retrospective Study of Gene Status and Clinical Outcome of Esophageal Squamous Cell Carcinoma(ESCC).
Actual Study Start Date : December 26, 2018
Estimated Primary Completion Date : April 1, 2019
Estimated Study Completion Date : April 1, 2019

Resource links provided by the National Library of Medicine


Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort
Lymph node metastasis Positive
good prognosis; without Lymph node metastasis.
Lymph node metastasis Negative
poor prognosis; with Lymph node metastasis.


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Gene test [ Time Frame: 2019-2 to 2019-4 ]
    466 Tumor-associated gene test by next-generation sequencing(NGS)


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   30 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Taihang Mountain area population in northern China.
Criteria

Inclusion Criteria:

  • Esophageal cancer patients who underwent surgery treatment, and postoperative pathological diagnosis was squamous cell carcinoma. Patients with ESCC have complete clinical information.

Exclusion Criteria:

  • Patients who also suffering from other tumors.
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03831828


Contacts
Layout table for location contacts
Contact: Junfeng Liu, MD 13931152296 13931152296@163.com

Locations
Layout table for location information
China, Hebei
Junfeng Liu Recruiting
Shijiazhuang, Hebei, China, 050000
Contact: Junfeng Liu, Professor    13931152296    13931152296@126.com   
Sponsors and Collaborators
LiuJunFeng
OrigiMed
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: LiuJunFeng, Director of thoracic surgery, Hebei Medical University Fourth Hospital
ClinicalTrials.gov Identifier: NCT03831828    
Other Study ID Numbers: HebeiMUFH-ESCC
First Posted: February 6, 2019    Key Record Dates
Last Update Posted: February 8, 2019
Last Verified: September 2018